Home > Insider Trading > Filing (0001179110-10-011227)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1461466	Dayton Misfeldt	C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-30	23,378,934	$0.28	23,378,934	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	445,516	$0.28	445,516	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	9,808,090	$0.00	33,187,024	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	186,900	$0.00	632,416	No	4	C	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	980,809	$0.00	9,808,090	$0.00
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	18,690	$0.00	186,900	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,091	Indirect	See Footnote

Footnotes

Mr. Misfeldt is a partner of Bay City Capital LLC, a Delaware limited liability company ("BCC"). BCC is the manager of Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"). Management V is the general partner of Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC , as the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. Mr. Misfeldt, BCC and Management V disclaim beneficial ownership with respect to the securities reported in this Form 4, except to the extent of their pecuniary interest therein.
These securities are held by Fund V.
These securities are held by Co-Investment V.
These securities are held by BCC.
The Series A Preferred Stock automatically converted into common stock in accordance with the terms of the applicabale Certificate of Designation of the Issuer on a 1-for-10 basis and had no expiration date.